← Leaderboards

James A Fagin

Sloan-Kettering Inst Can Research

Google Scholar ↗PubMed ↗ORCID ↗

$27,970,638

Attributed

$30,426,290

Total exposure

15

Grants

10

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$40,746,390 · 16

By mechanism

R01$22,273,818 · 6

P50$13,249,228 · 5

U09$2,569,000 · 1

T32$1,263,430 · 1

RC1$999,914 · 1

R21$391,000 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Timothy An-Thy Chan$21,076,830
Andrew Lin$444,768
Eric Sherman$201,870

Others in their field

Top investigators on “Malignant Neoplasm Of Thyroid”

David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
Keri Hammel · The Emmes Company, Llc$17,992,237
Stanley R Hamilton · Johns Hopkins University$17,360,724
Larry Arthur$15,377,757
Ignacio I. Wistuba · Ut Southwestern Medical Center$15,303,923
Matthew D Ringel · Ohio State University$14,394,679

Research focus

Malignant Neoplasm Of ThyroidThyroid GlandSignal TransductionPathway InteractionsTumorMutationBraf GeneProgramsOncogenicResponseCellsMalignant NeoplasmsMap Kinase GeneGene ExpressionBaseMeksGenesOncogenesMutantThyroid NeoplasmMouse ModelGrowthMolecularIn Vivo

Grant awards (104)

Improving efficacy of radioiodine treatment of thyroid cancer$471,416

R01 · FY2025 · CA · contact PI

Targeting immune suppressive microenvironment in ATC$440,718

R01 · FY2025 · CA · contact PI

Improving efficacy of radioiodine treatment of thyroid cancer$447,845

R01 · FY2024 · CA · contact PI

Targeting immune suppressive microenvironment in ATC$418,682

R01 · FY2024 · CA · contact PI

Improving efficacy of radioiodine treatment of thyroid cancer$461,989

R01 · FY2023 · CA · contact PI

Targeting immune suppressive microenvironment in ATC$431,902

R01 · FY2023 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$426,550

R01 · FY2023 · CA · contact PI

Improving efficacy of radioiodine treatment of thyroid cancer$461,989

R01 · FY2022 · CA · contact PI

Targeting immune suppressive microenvironment in ATC$431,902

R01 · FY2022 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$418,019

R01 · FY2022 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$158,283

T32 · FY2022 · CA

Improving efficacy of radioiodine treatment of thyroid cancer$471,416

R01 · FY2021 · CA · contact PI

Targeting immune suppressive microenvironment in ATC$440,718

R01 · FY2021 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$426,550

R01 · FY2021 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$163,914

T32 · FY2021 · CA

Oncogenic Events in Thyroid Neoplasia$449,000

R01 · FY2020 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$426,550

R01 · FY2020 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$146,134

T32 · FY2020 · CA

Molecular Pathophysiology of Thyroid Cell Growth$426,550

R01 · FY2019 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$415,645

R01 · FY2019 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$144,245

T32 · FY2019 · CA

SPORE in Thyroid Cancer$2,136,667

P50 · FY2018 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$428,500

R01 · FY2018 · CA · contact PI

Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling$351,404

P50 · FY2018 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$147,696

T32 · FY2018 · CA

Administrative Core$116,655

P50 · FY2018 · CA · contact PI

Developmental Research Program$70,985

P50 · FY2018 · CA · contact PI

Career Development Program$70,985

P50 · FY2018 · CA · contact PI

SPORE in Thyroid Cancer$2,136,667

P50 · FY2017 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$428,500

R01 · FY2017 · CA · contact PI

Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling$329,148

P50 · FY2017 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$138,862

T32 · FY2017 · CA

Administrative Core$119,921

P50 · FY2017 · CA · contact PI

Developmental Research Program$66,488

P50 · FY2017 · CA · contact PI

Career Development Program$66,488

P50 · FY2017 · CA · contact PI

SPORE in Thyroid Cancer$2,008,468

P50 · FY2016 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$428,500

R01 · FY2016 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$391,600

R01 · FY2016 · CA · contact PI

Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling$330,397

P50 · FY2016 · CA · contact PI

Administrative Core$121,775

P50 · FY2016 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$70,248

T32 · FY2016 · CA

Career Development Program$64,904

P50 · FY2016 · CA · contact PI

Developmental Research Program$64,904

P50 · FY2016 · CA · contact PI

SPORE in Thyroid Cancer$2,029,832

P50 · FY2015 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$391,600

R01 · FY2015 · CA · contact PI

Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling$329,528

P50 · FY2015 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$133,100

T32 · FY2015 · CA

Administrative Core$117,841

P50 · FY2015 · CA · contact PI

Career Development Program$64,682

P50 · FY2015 · CA · contact PI

Developmental Research Program$64,682

P50 · FY2015 · CA · contact PI

SPORE in Thyroid Cancer$2,008,466

P50 · FY2014 · CA · contact PI

Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling$402,117

R01 · FY2014 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$379,852

R01 · FY2014 · CA · contact PI

Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling$330,215

P50 · FY2014 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$136,210

T32 · FY2014 · CA

Administrative Core$120,886

P50 · FY2014 · CA · contact PI

Developmental Research Program$63,620

P50 · FY2014 · CA · contact PI

Career Development Program$63,620

P50 · FY2014 · CA · contact PI

Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling$414,552

R01 · FY2013 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$368,104

R01 · FY2013 · CA · contact PI

Head and Neck Training Program in Surgical Oncology$24,738

T32 · FY2013 · CA

Oncogenic Events in Thyroid Neoplasia$450,546

R01 · FY2012 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$390,619

R01 · FY2012 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$450,546

R01 · FY2011 · CA · contact PI

A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery$499,914

RC1 · FY2010 · CA

Oncogenic Events in Thyroid Neoplasia$464,480

R01 · FY2010 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$390,958

R01 · FY2010 · CA · contact PI

A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery$500,000

RC1 · FY2009 · CA

Oncogenic Events in Thyroid Neoplasia$459,333

R01 · FY2009 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$390,958

R01 · FY2009 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$413,621

R01 · FY2008 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$390,958

R01 · FY2008 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$406,875

R01 · FY2007 · CA · contact PI

Paracrine IGF/GFBP Interactions In Vivo$402,007

R01 · FY2007 · DK · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$390,958

R01 · FY2007 · CA · contact PI

Molecular Pathophysiology of Thyroid Cell Growth$407,043

R01 · FY2006 · CA · contact PI

Paracrine IGF/GFBP Interactions In Vivo$262,379

R01 · FY2006 · DK · contact PI

Oncogenic Events in Thyroid Neoplasia$244,691

R01 · FY2006 · CA · contact PI

Paracrine IGF/GFBP Interactions In Vivo$155,262

R01 · FY2006 · DK · contact PI

Oncogenic Events in Thyroid Neoplasia$129,630

R01 · FY2006 · CA · contact PI

Oncogenic Events in Thyroid Neoplasia$360,725

R01 · FY2005 · CA

Paracrine IGF/GFBP Interactions In Vivo$356,409

R01 · FY2005 · DK

Paracrine IGF/GFBP Interactions In Vivo$356,409

R01 · FY2004 · DK

MOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTH$344,250

R01 · FY2004 · CA

Oncogenic Events in Thyroid Neoplasia$324,653

R01 · FY2004 · CA

Paracrine IGF/GFBP Interactions In Vivo$377,994

R01 · FY2003 · DK

Oncogenic Events in Thyroid Neoplasia$324,653

R01 · FY2003 · CA

MOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTH$309,825

R01 · FY2003 · CA

BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION$1,153,000

U09 · FY2002 · RG

BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION$610,000

U09 · FY2002 · RG

MOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTH$309,825

R01 · FY2002 · CA

PARACRINE IGF/IGFBP INTERACTIONS IN VIVO$282,939

R01 · FY2002 · DK

BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION$392,000

U09 · FY2001 · RG

BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION$391,000

U09 · FY2001 · RG

PARACRINE IGF/IGFBP INTERACTIONS IN VIVO$276,789

R01 · FY2001 · DK

ONCOGENIC EVENTS IN THYROID NEOPLASIA$276,775

R01 · FY2001 · CA

MOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTH$275,400

R01 · FY2001 · CA

BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION$23,000

U09 · FY2001 · RG

Molecular pathophysiology of thyroid cell growth$0

M01 · FY2001 · RR

N-acetylcysteine as a Potential Treatment for Methamphetamine Dependence$391,000

R21 · FY2000 · RG

ONCOGENIC EVENTS IN THYROID NEOPLASIA$283,748

R01 · FY2000 · CA

PARACRINE IGF/IGFBP INTERACTIONS IN VIVO$270,819

R01 · FY2000 · DK

MOLECULAR PATHOPHYSIOLOGY OF THYROID CELL GROWTH$240,975

R01 · FY2000 · CA

Molecular pathophysiology of thyroid cell growth$0

M01 · FY2000 · RR